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Abstract
Background: Flaxseed promotes bone health and possibly induces bone regeneration. However, the capacity of flaxseed to
induce the differentiation of stem cells into osteoblasts remains unreported. Accordingly, this study aimed to determine the
effects of flaxseed extract on the osteoblast differentiation potential of stem cells derived from human exfoliated deciduous
teeth (SHED).
Methods: SHED cultured in osteoblast induction media (OIM) were treated with 4 mg/mL flaxseed extract. RNA was collected and
extracted with Total RNA Mini Kit (Geneaid) from cells cultured at days 1, 3, 7, 14, and 21 and subjected to reverse-transcriptase
PCR for osteoblast markers (OSX, OCN, and DMP1). Alkaline phosphatase (ALP) activity was determined by ALP assay, and Alizarin
Red-S staining was performed to evaluate calcium deposition in SHED.
Results: All osteoblast markers were expressed in all samples analyzed. OSX expression was reduced in the SHED treated with
flaxseed extract. In addition, the SHED treated with flaxseed extract had lower ALP activity than the control (p < 0.05). Calcium
deposition was positive in the SHED cultured in OIM only.
Conclusions: Flaxseed can reduce the expression of osteoblast markers, ALP activity, and calcium deposition in SHED. Thus,
flaxseed potentially inhibits the osteoblast differentiation of SHED.
K e y w o r d s : flaxseed extract, human exfoliated deciduous teeth, osteoblast differentiation, stem cells

INTRODUCTION

Dental pulp tissue is an attractive source of
mesenchymal stem cells (MSCs) because of its readily
accessible and high yield source.9 In addition, stem cells
from dental pulp possess similar gene expression and
comparable regenerative potential to bone marrow
MSCs.10 Previously, we have shown that 4 mg/mL
flaxseed extract influences the bioavailability and growth
of stem cells from human deciduous teeth (SHED).11
SHED is a type of MSCs that can differentiate into
multiple cell lineages, including osteoblasts.12 The
osteogenic potential of SHED has been demonstrated
previously.13,14 In specific, SHED can differentiate into
osteoblast cells when cultured in osteoblast induction
media containing ß-glycerophosphate, ascorbic acid, and
dexamethasone.15,16 Moreover, the expression levels of
osteoblast-related genes increase in SHED cultured in
the presence of growth factors, indicating the application
of SHED in tissue engineering because of its osteogenic
differentiation potential.14

Flaxseed (Linum usitatissimum) contains beneficial
compounds recognized for its health benefits. Flaxseed
has attracted considerable interest because of its
potential benefits associated with its biologically active
components, such as approximately 59% a-linoleic acid
and lignan secoisolaricirecinol diglycoside (SDG).1–4 These
compounds may exert protective effects on bone
formation and bone metabolism. Consuming food rich in
omega-3, such as flaxseed, improves bone health.5 The
consumption of flaxseed also alleviates menopausal
effects and osteoporosis.6 Flaxseed extract promotes
bone health, especially in estrogen-deficient individuals,
and possibly induces bone regeneration.6–8
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Bone regeneration involves the physiological process of
bone formation during normal fracture healing and is
involved in continuous remodeling throughout adult
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life.17 Given their minimal side effects, natural
compounds obtained from natural resources give added
value in regenerative medicine. Although flaxseed extract
affects bone formation, its effect in inducing stem cells to
differentiate into osteoblasts has not been reported.
Hence, this study aimed to determine the effects of
flaxseed extract on the osteoblast differentiation
potential of SHED.
METHODS
Culture of SHED
SHED (ALLCells, USA) were cultured in complete growth
media (alpha-MEM; 10% FBS; 0.5% Pen-Strep) until
confluence. SHED at 80%–90% confluence were
subjected to osteoblast differentiation. The complete
growth medium was replaced with osteoblast induction
media (OIM) to initiate differentiation.14,18 The cells were
incubated in 5% CO2 incubator at 37°C for 21 days.
SHED cultured in complete growth media and OIM were
treated with or without 4 mg/mL flaxseed extract. The
flaxseed extract was prepared, and the optimum
concentration of extract was determined as previously
described.11 Four groups were set up for the analysis:
SHED cultured in growth media alone (A), SHED cultured
in growth media treated with 4 mg/mL flaxseed extract
(B), SHED cultured in OIM alone (C), and SHED cultured in
OIM treated with 4 mg/mL flaxseed extract (D).
Alkaline phosphatase activity of SHED
SHED were seeded in a 12-well plate (1 mL of 5 × 104 cell
suspension/well) and placed in 5% CO2 incubator until
confluence. For background control, 1 mL of media
(without cells) was aliquoted into the same 12 well plate.
The media were discarded and replaced with media
consisting of growth media as negative control, OIM as
positive control, growth media with 4 mg/mL flaxseed
extract, and OIM with 4 mg/mL extract. Alkaline
phosphatase (ALP) activity of SHED was evaluated at days
1, 3, 7, 14, and 21 by ALP assay.
Alizarin red-s staining for the calcium deposition of
SHED
SHED (1 × 105 cells) were seeded in a 6-well plate in OIM
and cultured in 5% CO2 incubator until confluence. The
media was discarded and replaced with media
containing 4 mg/mL flaxseed extract. The cells were
maintained in 5% CO2 incubator. The media was replaced
every 3 days. Calcium deposition of SHED was analyzed
at days 14 and 21 by using Alizarin Red-S staining. The
stained mineral deposits were viewed under an inverted
phase contrast microscope (Leica, Germany). SHED
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cultured in OIM without flaxseed extract served as
control.
Treatment of SHED for gene expression analysis
SHED (1 × 106 cells) were cultured in OIM and treated
with 4 mg/mL flaxseed extract. Non-treated SHED
cultured in OIM acted as control. The cells were collected
at days 1, 3, 7, 14, and 21. RNA was extracted using Total
RNA Mini Kit (Geneaid, Korea). Approximately 20 ng of
total RNA was used for cDNA synthesis (ReverTra Ace
qPCR Master Mix, Toyobo, Japan) and subjected to
reverse-transcriptase PCR analysis for osteoblast
markers OSX, DMP1, and OCN by using primer sequences
as described previously.19 Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as the internal
positive control.
Statistical analysis
All data were expressed as mean (±SD) from at least
three independent experiments and were subjected
ANOVA and t-test by using SPSS software (SPSS version
17). Statistical significance was considered at p < 0.05.
RESULTS
ALP activity
The ALP activity of all groups was detectable after 3 days
of incubation. The ALP activity of groups A, B, and D
gradually increased until day 21. The ALP activity of
group C gradually increased from day 3 until day 14 and
then significantly decreased at day 21 (p < 0.05) (Figure
1). A significant difference in ALP activity was found
between groups A and B at day 14 (p < 0.05, t-test) but
not at day 21 (p > 0.05). Similarly, the ALP activity of the
SHED cultured in OIM (C) was significantly higher than
that of the SHED treated with flaxseed (D) at day 14 (p <
0.01, t-test) but not at day 21 (p > 0.05).
Calcium deposition
The calcium deposition of SHED was assessed using
Alizarin Red-S staining at days 14 and 21. The SHED
cultured in OIM were positively stained at day 14, and
the nodules of the mineralized matrix were strongly
stained at day 21. A weak staining of Alizarin Red-S was
observed in the SHED cultured in OIM treated with 4
mg/mL flaxseed extract at day 14. In addition, the
formation of mineralized nodules at day 21 was lesser
than that at day 14 (indicated by a weak staining of
Alizarin Red-S). By contrast, Alizarin Red-S staining was
negative in the other groups, whereas no visible staining
of Alizarin Red-S was observed on the SHED cultured in
growth media with or without flaxseed extract at days 14
and 21 (Figure 2).

April 2021 | Vol. 25 | No. 1

Flaxseed extract on osteoblast differentiation of SHED 3

FIGURE 1. Intracellular ALP activity of SHED treated with and without flaxseed extract cultured in growth media and
osteoblast induction media. Values are expressed as means ± SD (n = 3)
SHED cultured in growth media
SHED (A)
SHED + flaxseed (B)
Day 14

SHED cultured in osteoblast induction media
SHED (C)
SHED + flaxseed (D)

Day 21

FIGURE 2. Plate view of SHED stained with Alizarin Red Solution (upper row) and microscopic view at 10× magnification
(lower row) observed at days 14 and 21
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TABLE 1. Expression of osteoblast markers on SHED cultured in osteoblast induction media (OIM) (treated with and
without flaxseed)

Day
1
3
7
14
21

SHED only
(control)
N.D.
N.D.
1.3569 ± 0.0707
1.1759 ± 0.0548
0.3586 ± 0.0170

OSX
SHED + flaxseed
0.8141 ± 0.0320
0.7931 ± 0.0389
0.3756 ± 0.0077*
1.1677 ± 0.0588
1.2683 ± 0.0739*

SHED only
(control)
N.D.
1.1403 ± 0.0378
1.1113 ± 0.0397
0.8281 ± 0.0319
0.9022 ± 0.0525

DMP1
SHED + flaxseed
1.1459 ± 0.0266
1.0036 ± 0.0548*
1.2675 ± 0.0021*
0.5102 ± 0.0090*
0.1097 ± 0.0396*

OCN
SHED only
(control)
1.0692 ± 0.0809
0.5201 ± 0.0193
1.4015 ± 0.0875
0.9171 ± 0.1005
1.5837 ± 0.0841

SHED + flaxseed
0.9365 ± 0.0305
1.2222 ± 0.0607*
1.0532 ± 0.0328*
2.0487 ± 0.0661*
1.0349 ± 0.0563*

Expression level of each gene was measured and normalized to GAPDH (housekeeping gene) and expressed as average intensity value
(AIV) (means ± SD, n = 3). *Significant difference when compared with the control of the same day within the same group (p < 0.05).
N.D. = Not detected.
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FIGURE 3. Agarose gel view of GAPDH and osteoblast marker (OSX, DMP1, OCN) on SHED cultured in osteoblast induction
media treated with and without flaxseed extract (as control).
Expression of osteoblast markers
Analysis of gene expression on osteoblast markers was
only performed on samples collected from the SHED
cultured in OIM treated with or without 4 mg/mL
flaxseed extract. The band intensities were measured
using Chemidoc (BioRad, USA) and expressed as average
intensity value (Table 1). Figure 3 illustrates the gene
expression patterns observed in the analysis.

DMP1 was highly expressed at days 3 to 21, except for
day 1, where the expression was not detected in the
control. In the SHED treated with flaxseed, the
expression of DMP1 was observed from day 1 to day 21.
The DMP1 expression in the treatment group significantly
reduced at days 14 and 21 compared with that in the
control (p < 0.05).

OSX expression was detectable at days 7 to 21 in the
control, whereas day 7 recorded the highest and day 21
recorded the lowest expression. By contrast, OSX
expression was detectable at days 1 to 21; it significantly
reduced at day 7 in the treatment group but significantly
increased at day 21 compared with the control (p < 0.05).

Overall, OCN was strongly expressed in all five days (1, 3,
7, 14, and 21) in the control and treatment groups.
Although the expression of OCN fluctuated in both
groups, it significantly increased at day 14 and reduced
at day 21 in the treatment group compared with the
control (p < 0.05).
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DISCUSSION
Osteogenesis
involves
the
differentiation
of
mesenchymal cells into pre-osteoblasts and osteoblasts,
leading to the synthesis and deposition of bone matrix
proteins.20 Osteoblast differentiation undergoes proliferation,
matrix maturation, and mineralization, which are
regulated by different transcription factors and signaling
proteins.21 The current study confirmed the potential of
SHED to differentiate into osteoblast-like lineage when
cultured under specific induction media.13,14 We
demonstrated the differentiation of SHED into osteoblast
lineage by ALP and calcium deposition analysis and
positive expression of osteoblast-related markers as
presented previously.14 Nonetheless, the addition of
flaxseed extract affected the ability of SHED to undergo
osteoblast differentiation. ALP is a well-known marker of
early osteoblast differentiation stage. ALP is a cell surface
protein ubiquitously expressed by several cell types and
is used for screening pre-osteoblasts.22 ALP activity
peaked at the second week of culture at about day 14
and then decreased with the onset of mineralization,
which is a typical positive indication.23 In the present
study, flaxseed extract reduced the osteoblast
differentiation potential of SHED. The ALP activity of the
SHED cultured in OIM alone resembled the normal
phases of osteoblast differentiation process. In specific,
ALP activity started to increase from day 7, peaked at day
14, and ten significantly decreased at day 21. By contrast,
the ALP activity of the SHED cultured in OIM treated with
flaxseed significantly reduced at day 14 compared with
that of the control. In addition, the ALP activity of the
SHED treated with flaxseed cultured in normal growth
media also reduced. This result might be additional
evidence showing that flaxseed reduces the osteoblast
differentiation potential of SHED.

differentiation potential of SHED in the presence of
flaxseed extract. Osterix (OSX) is an osteoblast-specific
transcription
factor
important
for
osteoblast
differentiation and bone formation and is also an early
osteoblast marker.25 Although the expression of OSX was
only detectable from day 7 onward in control, it was
consistent with the normal phases of osteoblast
differentiation as demonstrated in the ALP analysis
results that ALP activity increased from day 7, peaked at
day 14, and reduced at day 21. In the treatment group,
OSX was expressed at all days analyzed with highest
expression at day 21 compared with the control. This
result might be due to the continuous osteoblast
differentiation at this stage. ALP results revealed that ALP
activity slightly increased at day 21 in the treatment
group. In comparison to control, ALP activity reduced at
day 21, which could be related to reduction of OSX
expression.
Dentin matrix protein 1 (DMP1) expression is localized in
the mineralized matrix of bone; it is constitutively
expressed during osteoblast differentiation.26,27 In the
present analysis, DMP1 expression reduced from day 14
to day 21 in the flaxseed-treated group compared with
the control. Osteocalcin (OCN) is a late-stage marker of
osteogenic differentiation.28 In the present study, OCN
was expressed in all days and peaked at day 21 in the
control, which can be related to the final phase of
mineralization. Intense Alizarin Red-S staining was
observed at day 21 in the control, confirming that
mineralization is related to the high DMP1 and OCN
expression. By contrast, the reduction in DMP1 and OCN
expression in the flaxseed-treatment group at day 21
could be related to the reduced ALP activity and weak
Alizarin Red-S staining, especially at days 14 and 21.

Osteoblast differentiation was also analyzed by calcium
deposition through Alizarin Red-S staining. Intense
Alizarin Red-S staining and mineralized nodules were
observed in the SHED cultured in OIM alone at day 21.
Conversely, a weaker staining was observed and only few
mineralized nodules were detected in the SHED cultured
in OIM treated with flaxseed at day 21. This finding
further supports that flaxseed extract reduces the
osteoblast differentiation of SHED and thus reduces
calcium deposition. Mineralization is the final phase of
osteoblast differentiation, where the mineral matrix,
which predominately contains calcium phosphate in the
form of hydroxyapatite, is secreted and deposited by
mature osteoblasts.24 In the present study, SHED
cultured in OIM exhibited normal osteoblast
differentiation, but the addition of flaxseed extract
reduced the differentiation potential of SHED into
osteoblast-like lineage.

Overall, our result demonstrated that flaxseed crude
extract affected the osteoblast differentiation potential
of SHED by reducing the ALP level, calcium deposition,
and gene expression of osteoblast-related differentiation
markers. Flaxseed extract possibly modulated the activity
of ALP, the deposition of calcium, and the gene
expression of osteoblast-related markers. Previously, we
have shown that flaxseed extract contains high fatty acid
contents.11 Evidence presented over recent years has
shown that n-3 polyunsaturated fatty acids (PUFAs) are
beneficial for bone health.29,30 However, PUFAs result in
apoptosis at high concentrations and necrosis at even
higher concentrations.31 The inhibitory effects of fatty
acids depend on carbon chain length and double bond
number.32 The high contents of fatty acids in flaxseed
may inhibit SHED growth and other biological activities,
such as ALP activity and osteoblast differentiation.
However, further investigation is warranted in the future
to clarify this issue.

Gene expression levels of osteoblast markers OSX, DMP1,
and OCN were analyzed to evaluate the osteoblast

Most previous studies utilized pure flaxseed oil to study
the effects of flaxseed oil on bone health.8 The present
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study focused on flaxseed crude extract; the content and
ratio of the compound might vary with pure flaxseed oil
and thus affect the overall process of osteoblast
differentiation. The present study utilized stem cells from
dental pulp for in vitro analysis, whereas others used
osteoblast primary cell line as a starting material, which
could also affect the overall outcome. Nonetheless, the
current study provides additional information regarding
the utilization of 4 mg/mL flaxseed extract, which can
inhibit the osteoblast differentiation potential of SHED.

7.

CONCLUSIONS

10.

Flaxseed crude extract reduces ALP activity and calcium
deposition in SHED and affects the expression of
osteoblast markers. Thus, flaxseed can potentially inhibit
the osteoblast differentiation of SHED, suggesting its
possible application in the synthesis of natural-based
drugs that can control bone development. Nonetheless,
the actual mechanism must be elucidated in the future.
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